Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss
NCT05824065 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 504
Last updated 2024-02-16
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.
Conditions
- Female Pattern Baldness
Interventions
- DRUG
-
OMA102
1 mg
- DRUG
-
OMA102
2 mg
- DRUG
-
OMA102 - Placebo
Sponsors & Collaborators
-
EMS
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-31
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- Brazil
Study Locations
More Related Trials
-
Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)
NCT07303322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
NCT01325350 ·Status: COMPLETED ·Phase: PHASE2
-
BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.
NCT04880889 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia
NCT06558565 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
NCT06501924 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata
NCT05470413 ·Status: UNKNOWN ·Phase: PHASE3
-
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
NCT03488108 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study in Patients With Alopecia Areata
NCT04346316 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
NCT05888922 ·Status: RECRUITING ·Phase: PHASE3
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED
-
Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
NCT04594018 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Trial in Females With Female Pattern Hair Loss
NCT01145625 ·Status: COMPLETED ·Phase: PHASE3
-
ENERGI-F701 for Female Hair Loss Treatment
NCT03351322 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
NCT06762548 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
NCT07080931 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
NCT03689452 ·Status: COMPLETED ·Phase: NA
-
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Trial in Females for Female Pattern Hair Loss
NCT01226459 ·Status: COMPLETED ·Phase: PHASE3
-
Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia
NCT01231607 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
NCT00408798 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata
NCT03532958 ·Status: WITHDRAWN ·Phase: PHASE2
-
Treatment of Androgenetic Alopecia in Females, 12 Beam
NCT01016964 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
NCT05599243 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
NCT07012486 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients
NCT06440655 ·Status: RECRUITING ·Phase: NA